Search Results - Özkerim, Uğur

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Trastuzumab Rechallenge in HER2-Positive Metastatic Breast Cancer: A Promising Strategy for Enhanced Progression-Free Survival Post Ado-Trastuzumab Emtansine Progression

    Trastuzumab Rechallenge in HER2-Positive Metastatic Breast Cancer: A Promising Strategy for Enhanced Progression-Free Survival Post Ado-Trastuzumab Emtansine Progression by Altıntaş, Yunus Emre, Kınıkoğlu, Oğuzcan, Anıl Yıldız, Işık, Deniz, Özkerim, Uğur, Öksüz, Sıla, Tüylü, Tuğba Başoğlu, Sürmeli, Heves, Turan, Nedim, Odabaş, Hatice

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    The role of laboratory indices on treatment response and survival in breast cancer receiving neoadjuvant chemotherapy

    The role of laboratory indices on treatment response and survival in breast cancer receiving neoadjuvant chemotherapy by Yildirim, Sedat, Dogan, Akif, Akdag, Goncagul, Yüksel Yasar, Zeynep, Bal, Hamit, Kinikoglu, Oguzcan, Oksuz, Sila, Ozkerim, Ugur, Tunbekici, Salih, Yildiz, Hacer Sahika, Alan, Ozkan, Coban Kokten, Sermin, Isik, Deniz, Surmeli, Heves, Basoglu, Tugba, Sever, Ozlem Nuray, Odabas, Hatice, Yildirim, Mahmut Emre, Turan, Nedim

    Published in Scientific reports
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  3. 3
    Does Proton Pump Inhibitors Decrease the Efficacy of Palbociclib and Ribociclib in Patients with Metastatic Breast Cancer?

    Does Proton Pump Inhibitors Decrease the Efficacy of Palbociclib and Ribociclib in Patients with Metastatic Breast Cancer? by Odabas, Hatice, Dogan, Akif, Ozcelik, Melike, Yildirim, Sedat, Ozkerim, Ugur, Turan, Nedim, Yildirim, Mahmut Emre, Gumus, Mahmut

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: